Mr. Eugene Ng

Consultant Ophthalmologist and Retinal Surgeon

Dr. Tahira Saad

mr-eugene-ng

Consultant Ophthalmologist

Dr Tahira Saad is a Consultant Ophthalmologist with subspecialty fellowship training in medical retina and ocular inflammatory conditions. She is currently also working as a visiting Consultant at Addenbrookes Hospital as part of Cambridge University Hospitals NHS Foundation Trust, UK.

Spending her childhood and early adolescent years in Brisbane, Australia, she
obtained her first medical qualification from the University of Punjab, Lahore, Pakistan. She is passionate about education, both as a learner and as an educator, and after moving from Australia to Ireland in 1998, she became avidly involved in teaching undergraduate and graduate entry medical students at RCSI, which later led her to complete a post graduate qualification in Medical Education.

Dr Saad’s initial ophthalmic residency training began at the Mater Misericordiae University Hospital, Dublin in 2009. Following this, as a Clinical Registrar and Special Lecturer in Ophthalmology at University College Dublin (UCD) for 3 consecutive years. She completed her Membership with RCSI in 2013. Clinical service is an important part of Dr Saad’s acumen. To fulfill this she was appointed with initiative roles to provide ophthalmic care in areas of high volume service needs within medical ophthalmology and also treatments for Diabetic Eye Disease within the National Diabetic Screening and Treatment Program. In 2014 to 2015, Dr Saad undertook a Clinical Research Fellowship running clinical trials around Retinal Vein Occlusions and Inherited Retinal Degenerations Project contributing to the development of the All Ireland Inherited Retinal Diseases Registry. Thereafter in 2016 and 2017, she undertook a fellowship in Medical Retina and Uveitis at the prestigious Moorfields Eye Hospital, London, UK, a world-class centre of excellence for ophthalmic education and research. Dr Saad is most excited about being part of the Beacon Eye Clinic Rapid Access team that will be at the forefront to deliver acute ophthalmic care in conjunction with the existing refractive surgery, glaucoma, vitreo-retinal, medical retina and uveitis subspeciality services.

5